Dáil Éireann Debate, Thursday - 14 May 2026
255. Deputy John Lahart asked the Tánaiste and Minister for Finance if he will review the application of 23% VAT on injectable prescription medicines, including Tirzepatide, having regard to price disparities with Northern Ireland; and if he will make a statement on the matter. [35894/26]
Amharc ar fhreagraAs the Deputy will be aware, it is a longstanding practice of the Minister for Finance not to comment, in advance of the Budget, on any tax matters that might be the subject of Budget decisions.
Any changes to VAT rates will be considered as part of the normal Budgetary process, which will include the publication in the coming months of the Tax Strategy Group papers.
